| Posted: May 18, 2018 |
Simplifying skin disease diagnosis with topical nanotechnology(Nanowerk News) In a new SLAS Technology commentary ("Simplifying Skin Disease Diagnosis with Topical Nanotechnology"), two authors of an article recently published in Nature Biomedical Engineering ("Abnormal scar identification with spherical-nucleic-acid technology") share more insight into their unique method for skin disease diagnosis using NanoFlare nanotechnology. |
| In particular, the authors address point-of-care diagnosis and image acquisition, which are the primary bottlenecks in efficient disease diagnosis. |
 |
| This vision of simplifying disease diagnosis using topically-applied nanotechnology could change the way skin diseases such as abnormal scars are diagnosed and managed. (Image: David Yeo, Ph.D., and Prof. Chenjie Xu, Ph.D.) |
| Authors David Yeo, Ph.D., and Prof. Chenjie Xu, Ph.D., of the School of Chemical and Biomedical Engineering at Nanyang Technological University (Singapore) use NanoFlare to enable biopsy-free disease diagnosis and progression monitoring in response to therapy. |
| It is a minimally-invasive, self-applied alternative that can reduce scarring and infection risks; improve accessibility to disease diagnosis; provide timely feedback of treatment efficacy; and reduce healthcare personnel time and attention, hence the overall healthcare burden. |
| This vision of simplifying disease diagnosis using topically-applied nanotechnology could change the way skin diseases such as abnormal scars are diagnosed and managed. |
| Source: SLAS (Society for Laboratory Automation and Screening) |
